Capella 4300 Assessment 4

Assessment 4 And Now the Finale (Goals and Action Plan)

Name:

Capella University

PSYC-FPX 4300 Assessment 4:

Introduction to Addiction Treatment

Prof. Name:

Date

What’s Your Problem (Diagnostic Assessment)

Assessment Work Sheet

Client Name: Isabelle

Assessment Date: July 26, 2023

Substance Use History: Yes 

And Now the Finale

This case study revolves around Isabelle, who has been struggling with an addiction to oxycodone. Oxycodone, a potent painkiller present in medications like Percocet and oxycontin, is widely prescribed and used in the nation for pain management in various medical conditions. Isabelle’s journey with oxycodone and subsequent use of weed to manage his pain will be discussed in this assessment, along with his diagnoses, recommended treatment plan, and long- and short-term goals.

Description of The Client Case:

Isabelle is a 56-year-old individual who spent his entire career working in construction. About ten years ago, he underwent back surgery, which resulted in persistent pain that prevented him from continuing his work. To alleviate his pain, his doctor prescribed oxycodone. However, due to concerns related to addiction, his doctor advised him to undergo substance abuse therapy before continuing with the medication. Since then, Isabelle has not used oxycodone, but to cope with the pain, he has turned to daily use of weed. Isabelle’s life revolves around his wife and son, but he feels guilty for not being able to work and provide financial support due to his pain and addiction.

Client Diagnosis:

Isabelle’s condition is diagnosed as opioid abuse, uncomplicated, and opioid dependence, uncomplicated, based on the DSM-5 Diagnostic Codes (ICD-10-CM). The diagnosis is supported by the following symptoms:

1. Frequent use of opioids in larger quantities or for extended periods than prescribed.
2. Unsuccessful attempts to reduce or control opioid use.
3. Devoting a significant amount of time to obtain, use, or recover from opioids.
4. Intense desire or craving for opioids.
5. Interference with important responsibilities at work or home due to opioid use.
6. Continuing opioid use despite interpersonal or social problems related to it.
7. Giving up social, professional, or recreational activities due to opioid use.
8. Opioid use causing health risks.
9. Continued opioid use despite awareness of related physical or mental health issues.

Treatment Recommendation:

For Isabelle’s case, the recommended treatment plan includes the following approaches:

Detox Treatment:

Given the potential withdrawal symptoms and challenges in quitting oxycodone, a monitored detox process is advised, possibly in an inpatient setting, to ensure his safety and comfort. Medications may be provided to reduce cravings and discomfort during detox (Koehl et al., 2019).

Motivational Enhancement Therapy (MET):

This therapy focuses on helping individuals change their thoughts and behaviors. MET involves four tailored treatment sessions aimed at reviewing assessment data, setting future goals, and providing support for maintaining sobriety (Herscher et al., 2020).

Psychiatric Help:

Involving non-addictive, non-pharmacological pain management methods provided by psychologists can enhance prevention, treatment, and rehabilitation, reducing the likelihood of opiate misuse. Group discussion therapy is also recommended to encourage open communication and peer support for Isabelle (Brennan et al., 2022).

Music and Art Therapy:

These therapies are suggested to reduce Isabelle’s loneliness, depression, and weed smoking habits. Music and art therapy can provide effective mental relaxation and help improve mental health (Carter et al., 2023).

Cognitive Behavioral Therapy (CBT):

CBT can help change Isabelle’s perceptions and management of pain, reducing stress and improving pain coping mechanisms. CBT is considered an effective technique for chronic pain management (Lee & Cho, 2021).

Importance of Therapies:

Therapies are crucial in guiding patients towards healthier behaviors and improving their overall well-being. Group discussion therapy, music therapy, art therapy, and CBT play pivotal roles in modifying behaviors, fostering awareness, and providing guidance for positive health outcomes (Amini et al., 2022).

Ethical Concerns

In treating drug addiction, several ethical issues may arise, such as confidentiality, equal access to resources, respect for decision-making capacity, addressing disability, non-discriminatory practices, and fair distribution of resources (Brezel et al., 2019).

Short- and Long-Term Goals:

For Isabelle’s recovery, both short- and long-term goals have been identified. Short-term goals include leading a healthy lifestyle, building improved relationships with supportive individuals, experimenting with new activities, and seeking therapy for mental health. The long-term goals encompass resisting temptation, developing healthy friendships and relationships, and setting future goals with his wife to focus on a substance-free life (Krause et al., 2019).

Action Plan:

The recommended action plan focuses on stringent policies to control weed availability, forming monitoring committees, imposing penalties on suppliers and users, promoting counseling and rehabilitation centers, and involving families and peers in the treatment process to reduce weed smoking among the community (O’Donnell et al., 2022).

Conclusion:

In conclusion, the case of Isabelle highlights the risks and complications associated with opioid use and the importance of effective treatment approaches. Addressing the opioid abuse issue requires comprehensive treatment plans, ethical considerations, and the integration of various therapies to guide patients towards positive health outcomes and a drug-free life.

References

Amini, L., Silbert, S. K., Maude, S. L., Nastoupil, L. J., Ramos, C. A., Brentjens, R. J., Sauter, C. S., Shah, N. N., & Abou-el-Enein, M. (2022). Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion. Nature Reviews Clinical Oncology, 19(5), 342–355. https://doi.org/10.1038/s41571-022-00607-3 

Athy, A. E., Milojev, P., Gray, N. H., Osborne, D., Sibley, C. G., & Milfont, T. L. (2022). Clarifying longitudinal relations between individuals’ support for human rights and climate change beliefs. Journal of Environmental Psychology, 101875. https://doi.org/10.1016/j.jenvp.2022.101875 

Brennan, L., Sheill, G., O’Neill, L., O’Connor, L., Smyth, E., & Guinan, E. (2022). Physical therapists in oncology settings: experiences in delivering cancer rehabilitation services, barriers to care, and service development needs. Physical Therapy. https://doi.org/10.1093/ptj/pzab287 

Brezel, E. R., Powell, T., & Fox, A. D. (2019). An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated. Substance Abuse, 41(2), 1–5. Https://doi.org/10.1080/08897077.2019.1695706 

Carter, A. M., Dioso, E. R., Romero, B., Clinker, C. E., & Lucke-Wold, B. (2023). Complementary medicine and expressive arts therapy: adjuvant for recovery following neurosurgical procedures. OBM Integrative and Complementary Medicine, 8(1), 1–14. https://doi.org/10.21926/obm.icm.2301007 

Darnall, B. D., Mackey, S. C., Lorig, K., Kao, M.-C., Mardian, A., Stieg, R., Porter, J., debruyne, K., Murphy, J., Perez, L., Okvat, H., Tian, L., Flood, P., mcgovern, M., Colloca, L., King, H., Van Dorsten, B., Pun, T., & Cheung, M. (2019). Comparative Effectiveness of cognitive behavioral therapy for chronic pain and chronic pain self-management within the context of voluntary patient-centered prescription opioid tapering: The empower study protocol. Pain Medicine. Https://doi.org/10.1093/pm/pnz285 

Harris, R. A., Kranzler, H. R., Chang, K.-M., Doubeni, C. A., & Gross, R. (2019). Long-term use of hydrocodone vs. oxycodone in primary care. Drug and Alcohol Dependence, 205, 107524. Https://doi.org/10.1016/j.drugalcdep.2019.06.026 

Herscher, M., Fine, M., Navalurkar, R., Hirt, L., & Wang, L. (2020). Diagnosis and management of opioid use disorder in hospitalized patients. Medical Clinics of North America, 104(4), 695–708. Https://doi.org/10.1016/j.mcna.2020.03.003 

Koehl, J. L., Zimmerman, D. E., & Bridgeman, P. J. (2019). Medications for management of opioid use disorder. American Journal of Health-System Pharmacy, 76(15), 1097–1103. Https://doi.org/10.1093/ajhp/zxz105 

Krause, J. S., Dismuke-Greer, C. E., Reed, K. S., & Li, C. (2019). Employment status, hours working, and gainful earnings after spinal cord injury: relationship with pain, prescription medications for pain, and nonprescription opioid use. Spinal Cord. Https://doi.org/10.1038/s41393-019-0374-1 

Lee, S.-H., & Cho, S. J. (2021). Cognitive behavioral therapy and mindfulness-based cognitive therapy for depressive disorders. Major Depressive Disorder, 295–310. Https://doi.org/10.1007/978-981-33-6044-0_16 

O’Donnell, C., Demler, T. L., & Dzierba, C. (2022). Perceptions and barriers of adverse drug reaction reporting within inpatient state psychiatric facilities. Mental Health Clinician, 12(4), 247–253. Https://doi.org/10.9740/mhc.2022.08.247 

Poulsen, M. N., Asdell, P. B., Berrettini, W., McBryan, K., & Rahm, A. K. (2022). Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study. SSM – Mental Health, 2, 100151. https://doi.org/10.1016/j.ssmmh.2022.100151 

Samples, H., Williams, A. R., Crystal, S., & Olfson, M. (2022). Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes. Journal of Substance Abuse Treatment, 108774. https://doi.org/10.1016/j.jsat.2022.108774 

Teleki, S., Zsidó, A. N., Lénárd, L., Komócsi, A., Kiss, E. C., & Tiringer, I. (2021). Role of received social support in the physical activity of coronary heart patients: The health action process approach. Applied Psychology: Health And Well-being. https://doi.org/10.1111/aphw.12290 

Türkis, S. (2022, July 1). Use and effectiveness of creative art therapy in the treatment of Post- Traumatic Stress Disorder: a scoping review. Essay.utwente.nl. http://essay.utwente.nl/92434/ 

Weiss, A. J., Heslin, K. C., Stocks, C., & Owens, P. L. (2020, April 14). Table 4, ICD-9-CM and ICD-10-CM diagnosis codes defining opioid use disorder (OUD). Www.ncbi.nlm.nih.gov. Https://www.ncbi.nlm.nih.gov/books/NBK557173/table/sb256.tab7/ 

You, D. S., Mardian, A. S., Darnall, B. D., Chen, C.-Y. A., De Bruyne, K., Flood, P. D., Kao, M.-C., Karnik, A. D., McNeely, J., Porter, J. G., Schwartz, R. P., Stieg, R. L., & Mackey, S. C. (2021). A brief screening tool for opioid use disorder: empower study expert consensus protocol. Frontiers in Medicine, 8. Https://doi.org/10.3389/fmed.2021.591201

Zapata, J., Lesser, J., Recto, P., Moreno-Vasquez, A., & Idar, A. Z. (2022). Perceptions of community health workers during two concurrent national health crises: Opioid use disorder and COVID-19. Issues in Mental Health Nursing, 1–9. https://doi.org/10.1080/01612840.2021.2011508